RVX-208
-
- Application
- Inhibition (Inh)
- Purpose
- BET bromodomain inhibitor
- Characteristics
- RVX-208 is a potent BET bromodomain antagonist with IC50 of 0.510 μM for BD2, with approximately 170-fold selectivity over BD1. Increases apolipoprotein A-1 and HDL cholesterol in vitro and in vivo. Reduces atherosclerosis.
- Purity
- >98 %
- Chemical Name
- 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-4(3H)-quinzolinone
- Formula
- C20H22N2O5
- Solubility
- Soluble in DMSO (up to 75 mg/ml) or in Ethanol (up to 4 mg/ml).
-
-
- Restrictions
- For Research Use only
-
- Format
- Powder
- Precaution of Use
-
GHS – Classification
Not a dangerous substance - Storage
- -20 °C
-
- Background
- Epigenetics,Posttranslational modification,Bromodomain,Atherosclerosis,Chromatin,Cholesterol metabolism
- Molecular Weight
- 370.41
- CAS-No
- 1044870-39-4
-